Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Contingency management (CM) is a type of treatment used in the substance abuse field. Patients' behaviors are rewarded for adherence to a treatment plan. As an approach to treatment, contingency management emerged from the behavior therapy traditions in mental health. By most evaluations, contingency management procedures produce one of the largest effect sizes out of all mental health and educational interventions.
The purpose of this study is to perform a randomized, controlled trial to evaluate the ability of a culturally-tailored contingency management (CM) intervention to increase alcohol and drug abstinence among American Indian (AI) tribal members from two rural reservations in the Northwest.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CM for alcohol | Experimental | CM for alcohol |
|
| CM for drugs | Experimental | CM for drugs |
|
| CM for both substances | Experimental | CM for both substances |
|
| Non-Contingent group | Other | No CM for either substance, the Non-Contingent (NC) group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CM for Alcohol | Behavioral | Escalating reinforcement for alcohol abstinence. Alcohol-negative CM Participants draw chips out of a bowl containing 500 chips. Fifty percent of the chips will say "good job!" or a similar encouraging phrase, 41.8% of the chips will result in a small prize, 8% will result in a large prize, and 0.2% will result in a jumbo prize. |
| Measure | Description | Time Frame |
|---|---|---|
| Biochemically verified alcohol and/or drug abstinence | At every study visit, urine samples will be collected and analyzed for ethyl glucuronide and drugs. This helps assess Contingency Management as a treatment for alcohol and/or drug dependence. | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Self- reported data on alcohol and drug use | Measures used for self-reported data on alcohol and drug use:
| 24 weeks |
| Other substance use |
| Measure | Description | Time Frame |
|---|---|---|
| Measures used for descriptive purposes and to assess success of randomization. | We will measure psychopathology with the Brief Symptom Inventory, a self-report instrument that will assess levels of anxiety, depression, impulsiveness, at baseline to characterize the psychiatric severity of the sample that has been used in previous studies of American Indians. | 24 weeks |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mike McDonell, PhD | Washington State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Washington State University | Spokane | Washington | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33220122 | Derived | McDonell MG, Skalisky J, Burduli E, Foote A Sr, Granbois A, Smoker K, Hirchak K, Herron J, Ries RK, Echo-Hawk A, Barbosa-Leiker C, Buchwald D, Roll J, McPherson SM. The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community. Addiction. 2021 Jun;116(6):1569-1579. doi: 10.1111/add.15349. Epub 2021 Jan 14. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000076064 | Drug Misuse |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000431 | Ethanol |
| D004364 | Pharmaceutical Preparations |
| ID | Term |
|---|---|
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| CM for drugs | Behavioral | Escalating reinforcement for drug abstinence. Drug-negative participants will be invited to draw chips out of a bowl containing 500 chips. Fifty percent of the chips will say "good job!" or a similar encouraging phrase, 41.8% of the chips will result in a small prize, 8% will result in a large prize, and 0.2% will result in a jumbo prize. |
|
| CM for both substances | Behavioral | Escalating reinforcement for drug and alcohol abstinence. Drug- and alcohol-negative participants will be invited to draw chips out of a bowl containing 500 chips. Fifty percent of the chips will say "good job!" or a similar encouraging phrase, 41.8% of the chips will result in a small prize, 8% will result in a large prize, and 0.2% will result in a jumbo prize. |
|
| Non-Contingent group | Behavioral | Compensation for Non-Contingent control group participants is dependent only on providing urine samples, regardless of whether the urine tests are negative for alcohol and/or drugs. |
|
Amphetamine, methamphetamine, cocaine, and marijuana, will be measured by the same procedures described for urine tests of alcohol and drug metabolites. |
| 24 weeks |
| Self- reported data on health behaviors | We will also collect secondary outcome data on health behaviors that frequently correlate with alcohol and drug misuse with the following measures:
| 24 weeks |
| Measures used for descriptive purposes and to assess success of randomization. | The Fagerström Test of Nicotine Dependence will measure the presence and severity of nicotine dependence. | 24 weeks |
| Measures used for descriptive purposes and to assess success of randomization | Interest in alcohol and drug abstinence will be assessed by the Stages of Change Readiness and Treatment Eagerness Scale. | 24 weeks |
| Measures used for descriptive purposes and to assess success of randomization | In addition, other demographic, cultural, and cigarette smoking and alcohol use measures will be administered at baseline. These measures are part of the P20 Center Core measures. These measures include the Veteran's Rand-12 (already gathered as part of this study's protocol), the Behavioral Risk Factor Surveillance System Alcohol Survey, and demographic, cultural, and smoking behaviors (Behavioral Health Cooperative, Core Measures). | 24 weeks |